| Literature DB >> 29910851 |
Jamshid Yazdani Charati1, Ghasem Janbabaei2, Nadia Alipour3, Soraya Mohammadi3, Somayeh Ghorbani Gholiabad4, Afsaneh Fendereski2.
Abstract
AIM: This study aims to predict survival rate of gastric cancer patients and identify the effective factors related to it, using artificial neural network model.Entities:
Keywords: Artificial neural network; Gastric cancer; Survival analysis
Year: 2018 PMID: 29910851 PMCID: PMC5990918
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258
prevalence of symptoms before diagnosis in patients
| Symptoms | number | Frequency distribution | |
|---|---|---|---|
| have | Not having | ||
| gastric ache | 281 | 161(57.3) | 120(42.7) |
| Reflux | 281 | 30(10.7) | 251(89.3) |
| Weight Loss | 281 | 57(20.3) | 224(79.7) |
| Loss of appetite | 281 | 43(15.3) | 238(85.7) |
| Dysphagia | 280 | 40(14.3) | 240(85.7) |
| Nausea and vomiting | 280 | 81(28.9) | 199(71.1) |
| Constipation | 280 | 20(7.1) | 260(92.9) |
| Lethargy | 280 | 29(10.4) | 251(89.6) |
| Anemia | 282 | 24(8.5) | 258(91.5) |
| Gastric bleeding | 280 | 25(8.9) | 255(91.1) |
Figure 1Flowchart of classification of gastric cancer patients
Comparison of gastric cancer risk factors between training group and testing group
| Variables | n=283 | Training group (n=211) | Test group (n=72) | p-value |
|---|---|---|---|---|
| Gender | 0.641 | |||
| Female | 88 | 64 | 24 | |
| Male(BL) | 195 | 147 | 48 | |
| Type of histopathology | 0.392 | |||
| Adenocarcinoma | 229 | 166 | 63 | |
| Others | 10 | 6 | 4 | |
| Grade | 0.425 | |||
| Weak | 26 | 21 | 5 | |
| Middle or good(BL) | 115 | 84 | 31 | |
| Advanced stage of disease | 0.63 | |||
| Initial stage | 49 | 34 | 15 | |
| Local metastasis | 52 | 39 | 13 | |
| Distant metastasis | 101 | 78 | 23 | |
| Distant metastasis | 0.467 | |||
| Yes | 118 | 88 | 30 | |
| No | 62 | 50 | 12 | |
| Metastasis organ | 0.944 | |||
| Liver | 74 | 55 | 19 | |
| Others | 44 | 33 | 11 | |
| Type of treatment | 0.618 | |||
| Treatment1 | 180 | 136 | 44 | |
| Treatment2 | 18 | 11 | 7 | |
| Treatment3 | 61 | 46 | 15 | |
| Treatment4 | 24 | 18 | 6 | |
| Age of diagnosis | 0.177 | |||
| 70> | 165 | 118 | 47 | |
| ≥ 70 | 118 | 93 | 25 | |
| Status | 0.982 | |||
| Death | 208 | 155 | 53 | |
| Censor | 75 | 56 | 19 |
Figure 2.Kaplan-Meier survival estimates of gastric cancer patients by Stage of disease progression
Percentage of independent variables importance
| Examined Variables | importance | Standardized importance |
|---|---|---|
| Gender | 0.022 | 7.8 |
| The disease differentiation | 0.052 | 18.1 |
| Stage of disease progression | 0.265 | 93.3 |
| metastasis Member | 0.061 | 21.5 |
| Type of treatment | 0.284 | 100 |
| Age at time of diagnosis | 0.045 | 16 |